|
Patent Laws Affect Drug Innovation
August 27, 2009, Hindustan Times
India’s patent laws are stifling incremental
drug innovation, according to a report prepared
by the United States India Business Council
(USIBC) supported coalition for healthy India,
White & Case and Dua Consulting. Ranjit Shahani,
President of Organisation of Pharmaceutical
Producers of India who is also the Vice Chairman
& Managing Director of Novartis, said the
industry is in talk with the government for
bringing changes in Section 3 (d) of the Indian
Patent Act.
|